Suppr超能文献

微创治疗输尿管狭窄:一项 5 年回顾性研究。

Minimally invasive management of ureteral strictures: a 5-year retrospective study.

机构信息

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Department of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.

出版信息

World J Urol. 2019 Aug;37(8):1733-1738. doi: 10.1007/s00345-018-2539-5. Epub 2018 Oct 30.

Abstract

INTRODUCTION

Ureteric strictures are well-documented complications related to surgery or radiation therapy. Minimally invasive treatment using endoscopic dilatation or laser incision is the standard practice. There are no existing guidelines on which techniques to use in the treatment of different stricture types and a paucity of data regarding long-term results.

PURPOSE

Our study aimed to retrospectively assess the long-term efficacy of minimally invasive treatment in benign and malignant ureteric strictures.

MATERIALS AND METHODS

Over a 5-year period, 2007-2012, we analyzed the data of 59 consecutive patients undergoing minimally invasive treatment for symptomatic ureteric strictures. We excluded 16 patients from final analysis due to failed access or loss to follow-up. All patients but one were treated with antegrade, retrograde balloon or catheter dilatations. Successful outcome was defined as an asymptomatic, completely catheter free patient, with stable renal function.

RESULTS

43 patients were eligible for retrospective final analysis. The largest proportion of strictures occurred following surgery combined with radiotherapy 8/43 (19%). Preoperative decompression was required in 30/43 (70%). We identified 32/43 (75%) balloon dilatations, 10/43 (23%) catheter dilatations and 1/43 (2%) laser incision. Overall success rate was 31/43 (72%). All 6 recurrences occurred within 36 months, 4 within the first 12 months. 3/6 patients were successfully re-dilated.

CONCLUSION

Minimally invasive treatment is a worthwhile alternative in strictures due to previous radiation and/or surgical treatment of malignancies. Most recurrences occurred within the first year. However, late recurrences arise; therefore, patients should be subject to long-term follow-up. Moreover, re-dilatation may be required.

摘要

介绍

输尿管狭窄是与手术或放射治疗相关的已充分记录的并发症。使用内镜扩张或激光切开的微创治疗是标准的治疗方法。对于不同类型的狭窄,目前没有关于使用哪种技术的指南,并且关于长期结果的数据也很少。

目的

我们的研究旨在回顾性评估微创治疗良性和恶性输尿管狭窄的长期疗效。

材料和方法

在 2007 年至 2012 年的 5 年期间,我们分析了 59 例因症状性输尿管狭窄而行微创治疗的连续患者的数据。由于无法进入或随访丢失,我们排除了 16 例患者进行最终分析。除了一名患者外,所有患者均接受经皮逆行球囊或导管扩张术治疗。成功的结果定义为无症状、完全无导管的患者,且肾功能稳定。

结果

43 例患者有资格进行回顾性最终分析。最常见的狭窄发生在手术联合放疗后 8/43(19%)。30/43(70%)需要术前减压。我们发现 32/43(75%)球囊扩张,10/43(23%)导管扩张和 1/43(2%)激光切开。总体成功率为 31/43(72%)。所有 6 例复发均发生在 36 个月内,4 例发生在 12 个月内。3/6 例患者再次扩张成功。

结论

微创治疗对于因先前的放射治疗和/或恶性肿瘤手术治疗而引起的狭窄是一种有价值的替代方法。大多数复发发生在第 1 年内。然而,也会出现迟发性复发;因此,患者应进行长期随访。此外,可能需要重新扩张。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5fb/6684542/a03600b5981b/345_2018_2539_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验